Quick Answer
Regencell Bioscience Holdings Ltd reported Stockholders Equity of $4.86 million for the year ending 2025.
- Regencell Bioscience Holdings Ltd showed a decrease of -40.9% in Stockholders Equity from 2024 to 2025.
- This data is from Regencell Bioscience Holdings Ltd's annual report (Form 10-K), filed with the SEC on October 31, 2025.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 8 years of available data (2018 to 2025), Regencell Bioscience Holdings Ltd's Stockholders Equity has grown by 435.8%.
- Historical annual values: Fiscal year 2025: $4.86 million | Fiscal year 2024: $8.22 million | Fiscal year 2023: $12.03 million | Fiscal year 2022: $17.07 million | Fiscal year 2021: -$4.00 million | Fiscal year 2020: -$2.65 million | Fiscal year 2019: -$1.84 million | Fiscal year 2018: -$1.45 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: